We are live on ! Find out more
HLA

Hamilton Lane Advisors Portfolio holdings

AUM $149M
1-Year Est. Return 14.17%
This Fund
S&P 500
This Quarter Est. Return
-9.03%
1 Year Est. Return
-14.17%
3 Year Est. Return
+186.76%
5 Year Est. Return
+98.42%
10 Year Est. Return
+778.69%
AUM
$203M
AUM Growth
-$62M
Cap. Flow
-$31.6M
Cap. Flow %
-15.6%
Top 10 Hldgs %
66.28%
Holding
73
New
13
Increased
6
Reduced
20
Closed
25

Top Buys

Rank Stock Value
1
PANW icon
Palo Alto Networks
PANW
+$18.8M
2
NMBL
Nimble Storage, Inc.
NMBL
+$10.7M
3
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$10.1M
4
NFLX icon
Netflix
NFLX
+$5.37M
5
SAGE
Sage Therapeutics
SAGE
+$3.28M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$14.8M
2
BLUE
bluebird bio
BLUE
+$9.06M
3
AR icon
Antero Resources
AR
+$7.12M
4
HAPN
Happen Inc
HAPN
+$6.64M
5
KYNB
Kyntra Bio
KYNB
+$5.79M

Sector Composition

Rank Sector Weight
1 Communication Services 23.64%
2 Technology 22.66%
3 Healthcare 13.39%
4 Financials 10.05%
5 Industrials 3.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EA icon
51
Electronic Arts
EA
$53B
– –
-65,493
Closed -$4.36M
ESPR
52
DELISTED
Esperion Therapeutics
ESPR
– –
-23,847
Closed -$1.95M
GPRO icon
53
GoPro
GPRO
$121M
– –
-106,967
Closed -$5.64M
INGN icon
54
Inogen
INGN
$168M
– –
-5,114
Closed -$228K
NVAX icon
55
Novavax
NVAX
$1.21B
– –
-1,054
Closed -$235K
PBPB
56
DELISTED
Potbelly
PBPB
– –
-109,696
Closed -$1.34M
PTCT icon
57
PTC Therapeutics
PTCT
$5.8B
– –
-46,246
Closed -$2.23M
SUPN icon
58
Supernus Pharmaceuticals
SUPN
$2.6B
– –
-18,806
Closed -$319K
ISEE
59
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-85,496
Closed -$4.45M
ABMD
60
DELISTED
Abiomed Inc
ABMD
– –
-70,392
Closed -$4.63M
CALA
61
DELISTED
Calithera Biosciences, Inc
CALA
– –
-500
Closed -$71K
TTPH
62
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
– –
-371
Closed -$352K
ACHN
63
DELISTED
Achillion Pharmaceuticals
ACHN
– –
-29,846
Closed -$264K
ALDR
64
DELISTED
Alder Biopharmaceuticals
ALDR
– –
-22,359
Closed -$1.18M
TSRO
65
DELISTED
TESARO, Inc.
TSRO
– –
-20,142
Closed -$1.18M
MITL
66
DELISTED
Mitel Networks Corporation
MITL
– –
-117,303
Closed -$1.04M
FMI
67
DELISTED
Foundation Medicine, Inc.
FMI
– –
-28,809
Closed -$975K
JUNO
68
DELISTED
Juno Therapeutics, Inc.
JUNO
– –
-12,552
Closed -$669K
KITE
69
DELISTED
Kite Pharma, Inc.
KITE
– –
-22,504
Closed -$1.37M
RLYP
70
DELISTED
RELYPSA INC COM
RLYP
– –
-13,411
Closed -$444K
AWAY
71
DELISTED
HOMEAWAY INC COM
AWAY
– –
-29,491
Closed -$918K
ZU
72
DELISTED
ZULILY INC CLASS A COMMON STOCK
ZU
– –
-108,050
Closed -$1.41M
1 2
3

Similar funds

FFS
Flavin Financial Services Melbourne, Florida $149M AUM 14.79% 1-Year Est. Return
KCM
KM Capital Management Austin, Texas $149M AUM 18.7% 1-Year Est. Return
GCA
Gallagher Capital Advisors Argyle, Texas $148M AUM 20.92% 1-Year Est. Return
DAC
Dutch Asset Corp Selkirk, New York $149M AUM
RCM
Rockbridge Capital Management Alexandria, Virginia $149M AUM 1.06% 1-Year Est. Return
AWA
Authentikos Wealth Advisory Morgan Hill, California $148M AUM 9.86% 1-Year Est. Return
JWM
Jacksonville Wealth Management Jacksonville, Florida $148M AUM 23.77% 1-Year Est. Return
AWF
Alpha Wealth Funds Park City, Utah $149M AUM 10.03% 1-Year Est. Return

Hamilton Lane Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, Hamilton Lane Advisors held 73 positions worth $203M, down 23% from $265M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Hamilton Lane Advisors withdrew a net $31.6M in Q3 2015, closing 25 positions and reducing 20 holdings. Its most notable exit was bluebird bio, an estimated $9.06M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 24% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Hamilton Lane Advisors opened a new position in Palo Alto Networks worth $18.2M.

  • Hamilton Lane Advisors's largest Q3 2015 buy was Palo Alto Networks: 635,544 shares worth $18.2M.
  • Hamilton Lane Advisors added most to Sage Therapeutics in Q3 2015, an estimated $3.28M increase.
  • Hamilton Lane Advisors's biggest Q3 2015 reduction was Meta Platforms (Facebook), cutting an estimated $14.8M.
  • Hamilton Lane Advisors fully exited bluebird bio in Q3 2015, selling an estimated $9.06M.
  • Hamilton Lane Advisors's ten largest holdings make up 66% of its $203M portfolio in Q3 2015.
  • Hamilton Lane Advisors opened 13 new positions and closed 25 in Q3 2015.
  • Hamilton Lane Advisors's portfolio value fell 23% quarter-over-quarter to $203M.

Based on Hamilton Lane Advisors's 13F filing for Q3 2015, filed 19 Oct 2015.